• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便免疫化学检测比愈创木脂粪便潜血试验更适用于结直肠癌筛查。

Fecal immunological blood test is more appealing than the guaiac-based test for colorectal cancer screening.

机构信息

Département de médecine générale, Faculté de médecine, Université de Rennes 1, France.

Normandie Univ, Unicaen, Inserm U1086, Cancers et préventions, et CHU Caen, Caen, France.

出版信息

Dig Liver Dis. 2017 Nov;49(11):1267-1272. doi: 10.1016/j.dld.2017.08.018. Epub 2017 Aug 10.

DOI:10.1016/j.dld.2017.08.018
PMID:28867474
Abstract

BACKGROUND

The reasons for participation in fecal immunological testing (FIT) of subjects who were previously non-respondents to guaiac fecal occult blood testing (g-FOBT) have not been assessed.

POPULATION AND METHODS

We aimed to determine the reasons for current compliance with FIT among non-responders to g-FOBT, termed "converts‿, in a French district. A questionnaire was returned by 170 converts aged from 55 to 75 years (response rate 75.2% after exclusions).

RESULTS

The major barriers to participation in screening with g-FOBT were test-related: the test was perceived as complicated (24%) and it required three consecutive stools (28%). Among the test-related major determinants of FIT compliance was the perception that the test was less complicated than previous test (30%) and that a unique stool sample was required (29%). Among the non-test related major determinants of FIT compliance were the perception that the general practitioner was more convincing (31%) and the feeling to be more concerned because of age (21%). The reasons for compliance among converts did not differ according to age, sex, and rural or urban residence.

CONCLUSIONS

Our study demonstrated that the simplicity of FIT and the endorsement of practitioners were both major motivations for FIT compliance among non-respondents in at least two previous consecutive campaigns.

摘要

背景

既往对愈创木脂粪便潜血试验(g-FOBT)无反应的受试者参与粪便免疫化学检测(FIT)的原因尚未得到评估。

人群和方法

我们旨在确定法国某地区既往对 g-FOBT 无反应者(称为“转化者”)目前对 FIT 依从的原因。对年龄在 55 至 75 岁之间的 170 名转化者进行了问卷调查(排除后应答率为 75.2%)。

结果

参与 g-FOBT 筛查的主要障碍与检测相关:检测被认为复杂(24%),需要连续三次粪便样本(28%)。FIT 依从性的主要检测相关决定因素包括认为检测比之前的检测简单(30%)和只需要一份粪便样本(29%)。FIT 依从性的主要非检测相关决定因素包括认为全科医生更有说服力(31%)和因年龄增长而更关注(21%)。转化者的依从原因不因年龄、性别以及城乡居住而有所不同。

结论

我们的研究表明,FIT 的简便性和医生的认可均是既往至少连续两次筛查活动中无反应者依从 FIT 的主要动机。

相似文献

1
Fecal immunological blood test is more appealing than the guaiac-based test for colorectal cancer screening.粪便免疫化学检测比愈创木脂粪便潜血试验更适用于结直肠癌筛查。
Dig Liver Dis. 2017 Nov;49(11):1267-1272. doi: 10.1016/j.dld.2017.08.018. Epub 2017 Aug 10.
2
Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective.结直肠癌筛查中愈创木脂法与免疫粪便潜血试验的比较:患者视角
Scand J Gastroenterol. 2010 Nov;45(11):1345-9. doi: 10.3109/00365521.2010.497937. Epub 2010 Jun 21.
3
Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.在一项有组织的结直肠癌筛查计划中,免疫化学粪便潜血试验与愈创木脂粪便潜血试验的纵向依从性比较。
Cancer Prev Res (Phila). 2019 May;12(5):327-334. doi: 10.1158/1940-6207.CAPR-18-0091. Epub 2019 Mar 19.
4
Fecal occult blood test in colorectal cancer screening.结直肠癌筛查中的粪便潜血试验。
J Dig Dis. 2019 Feb;20(2):62-64. doi: 10.1111/1751-2980.12712. Epub 2019 Mar 5.
5
A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study.免疫化学粪便隐血试验比愈创木脂粪便隐血试验检测结直肠癌和高级腺瘤性息肉的检出率更高,尽管其顺应性较低。一项前瞻性、对照、可行性研究。
Int J Cancer. 2011 May 15;128(10):2415-24. doi: 10.1002/ijc.25574.
6
Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.用于检测血红蛋白的刷取粪便免疫化学检测法与基于愈创木脂的灵敏粪便潜血检测法在结直肠肿瘤检测中的比较。
Cancer. 2006 Nov 1;107(9):2152-9. doi: 10.1002/cncr.22230.
7
Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.在一项针对结直肠癌筛查计划中,对粪便隐血试验呈阳性的个体进行免疫化学检测:一项观察性研究。
Lancet Oncol. 2006 Feb;7(2):127-31. doi: 10.1016/S1470-2045(05)70473-3.
8
Detection of Colorectal Neoplasia in a Cohort Before and After the Change of Fecal Occult Blood Test in a French Colorectal Cancer Screening Program.在法国结直肠癌筛查计划改变粪便潜血试验前后队列中结直肠肿瘤的检测。
Am J Gastroenterol. 2018 Dec;113(12):1891-1899. doi: 10.1038/s41395-018-0367-2. Epub 2018 Oct 18.
9
[Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].[用于结直肠癌筛查中粪便潜血检测的化学或免疫检测?]
Gastroenterol Hepatol. 2009 Oct;32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3.
10
Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.粪便检测阴性的结直肠癌患者发生高级别腺瘤风险较低。
Gastroenterology. 2012 Mar;142(3):497-504. doi: 10.1053/j.gastro.2011.11.024. Epub 2011 Nov 19.

引用本文的文献

1
Colorectal cancer screening with faecal immunochemical test: Patterns of participation.粪便免疫化学检测用于结直肠癌筛查:参与模式
J Med Screen. 2024 Mar;31(1):15-20. doi: 10.1177/09691413231188275. Epub 2023 Jul 18.
2
Supply and quality of colonoscopy according to the characteristics of gastroenterologists in the French population-based colorectal-cancer screening program.根据法国人群结直肠癌筛查计划中胃肠病学家的特点评估结肠镜检查的供应和质量。
World J Gastroenterol. 2023 Mar 7;29(9):1492-1508. doi: 10.3748/wjg.v29.i9.1492.
3
Immunogenomic Biomarkers and Validation in Lynch Syndrome.
免疫基因组生物标志物与林奇综合征的验证。
Cells. 2023 Feb 2;12(3):491. doi: 10.3390/cells12030491.
4
Detection of Colorectal Neoplasia in a Cohort Before and After the Change of Fecal Occult Blood Test in a French Colorectal Cancer Screening Program.在法国结直肠癌筛查计划改变粪便潜血试验前后队列中结直肠肿瘤的检测。
Am J Gastroenterol. 2018 Dec;113(12):1891-1899. doi: 10.1038/s41395-018-0367-2. Epub 2018 Oct 18.